212 related articles for article (PubMed ID: 36082510)
1. Risk stratification and early detection biomarkers for precision HCC screening.
Lee YT; Fujiwara N; Yang JD; Hoshida Y
Hepatology; 2023 Jul; 78(1):319-362. PubMed ID: 36082510
[TBL] [Abstract][Full Text] [Related]
2. Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine.
Fujiwara N; Friedman SL; Goossens N; Hoshida Y
J Hepatol; 2018 Mar; 68(3):526-549. PubMed ID: 28989095
[TBL] [Abstract][Full Text] [Related]
3. Updating the Clinical Application of Blood Biomarkers and Their Algorithms in the Diagnosis and Surveillance of Hepatocellular Carcinoma: A Critical Review.
Shahini E; Pasculli G; Solimando AG; Tiribelli C; Cozzolongo R; Giannelli G
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901717
[TBL] [Abstract][Full Text] [Related]
4. Opportunities to address gaps in early detection and improve outcomes of liver cancer.
McMahon B; Cohen C; Brown RS; El-Serag H; Ioannou GN; Lok AS; Roberts LR; Singal AG; Block T
JNCI Cancer Spectr; 2023 May; 7(3):. PubMed ID: 37144952
[TBL] [Abstract][Full Text] [Related]
5. Glycoproteomic markers of hepatocellular carcinoma-mass spectrometry based approaches.
Zhu J; Warner E; Parikh ND; Lubman DM
Mass Spectrom Rev; 2019 May; 38(3):265-290. PubMed ID: 30472795
[TBL] [Abstract][Full Text] [Related]
6. Early detection of hepatocellular carcinoma: roadmap for improvement.
Melendez-Torres J; Singal AG
Expert Rev Anticancer Ther; 2022 Jun; 22(6):621-632. PubMed ID: 35514249
[TBL] [Abstract][Full Text] [Related]
7. International Liver Cancer Association (ILCA) white paper on hepatocellular carcinoma risk stratification and surveillance.
Singal AG; Sanduzzi-Zamparelli M; Nahon P; Ronot M; Hoshida Y; Rich N; Reig M; Vilgrain V; Marrero J; Llovet JM; Parikh ND; Villanueva A
J Hepatol; 2023 Jul; 79(1):226-239. PubMed ID: 36854345
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive evaluation of microRNA as a biomarker for the diagnosis of hepatocellular carcinoma.
Malik J; Klammer M; Rolny V; Chan HL; Piratvisuth T; Tanwandee T; Thongsawat S; Sukeepaisarnjaroen W; Esteban JI; Bes M; Köhler B; Swiatek-de Lange M
World J Gastroenterol; 2022 Aug; 28(29):3917-3933. PubMed ID: 36157551
[TBL] [Abstract][Full Text] [Related]
9. Alpha-Fetoprotein Detection of Hepatocellular Carcinoma Leads to a Standardized Analysis of Dynamic AFP to Improve Screening Based Detection.
Bird TG; Dimitropoulou P; Turner RM; Jenks SJ; Cusack P; Hey S; Blunsum A; Kelly S; Sturgeon C; Hayes PC; Bird SM
PLoS One; 2016; 11(6):e0156801. PubMed ID: 27308823
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma screening and diagnosis.
Sherman M; Colombo M
Semin Liver Dis; 2014 Nov; 34(4):389-97. PubMed ID: 25369301
[TBL] [Abstract][Full Text] [Related]
11. Extracellular mRNA detected by molecular beacons in tethered lipoplex nanoparticles for diagnosis of human hepatocellular carcinoma.
Wang X; Kwak KJ; Yang Z; Zhang A; Zhang X; Sullivan R; Lin D; Lee RL; Castro C; Ghoshal K; Schmidt C; Lee LJ
PLoS One; 2018; 13(6):e0198552. PubMed ID: 29879168
[TBL] [Abstract][Full Text] [Related]
12. Liquid biopsies for hepatocellular carcinoma.
Su YH; Kim AK; Jain S
Transl Res; 2018 Nov; 201():84-97. PubMed ID: 30056068
[TBL] [Abstract][Full Text] [Related]
13. Evaluating screening approaches for hepatocellular carcinoma in a cohort of HCV related cirrhosis patients from the Veteran's Affairs Health Care System.
Tayob N; Richardson P; White DL; Yu X; Davila JA; Kanwal F; Feng Z; El-Serag HB
BMC Med Res Methodol; 2018 Jan; 18(1):1. PubMed ID: 29301497
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular Carcinoma Risk Stratification by Genetic Profiling in Patients with Cirrhosis.
Fujiwara N; Hoshida Y
Semin Liver Dis; 2019 May; 39(2):153-162. PubMed ID: 30912093
[TBL] [Abstract][Full Text] [Related]
15. Newer markers for hepatocellular carcinoma.
Marrero JA; Lok AS
Gastroenterology; 2004 Nov; 127(5 Suppl 1):S113-9. PubMed ID: 15508074
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma surveillance in the 21st century: Saving lives or causing harm?
Hanouneh IA; Alkhouri N; Singal AG
Clin Mol Hepatol; 2019 Sep; 25(3):264-269. PubMed ID: 30827081
[TBL] [Abstract][Full Text] [Related]
17. Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements.
Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma
J Gastroenterol Hepatol; 2010 Apr; 25(4):657-63. PubMed ID: 20492323
[TBL] [Abstract][Full Text] [Related]
18. Shaping the future management of hepatocellular carcinoma.
Abou-Alfa G; Colombo M
Semin Liver Dis; 2013 Feb; 33 Suppl 1():S20-3. PubMed ID: 23457036
[TBL] [Abstract][Full Text] [Related]
19. Current and Emerging Tools for Hepatocellular Carcinoma Surveillance.
Adeniji N; Dhanasekaran R
Hepatol Commun; 2021 Dec; 5(12):1972-1986. PubMed ID: 34533885
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis-Associated Liver Cancer: Gaps and Opportunities to Improve Care.
McMahon B; Block J; Block T; Cohen C; Evans AA; Hosangadi A; London WT; Sherman M;
J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26626106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
